Scarica l'app Stockscreener
8.31
1.34%
0.11
Dopo l'orario di chiusura:
8.31
Precedente Chiudi:
$8.20
Aprire:
$8.35
Volume 24 ore:
57,867
Relative Volume:
0.52
Capitalizzazione di mercato:
$479.57M
Reddito:
$181.68M
Utile/perdita netta:
$20.37M
Rapporto P/E:
23.78
EPS:
0.3495
Flusso di cassa netto:
$17.31M
1 W Prestazione:
-4.70%
1M Prestazione:
-1.07%
6M Prestazione:
-1.89%
1 anno Prestazione:
+22.21%
Intervallo 1D:
$8.18
$8.35
Intervallo di 1 settimana:
$8.17
$8.78
Portata 52W:
$6.50
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.31 | 503.23M | 181.68M | 20.37M | 17.31M | 0.3495 |
TAK
Takeda Pharmaceutical Co Adr
|
17.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.53 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.80 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
69.69 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
541.70 | 20.39B | 3.17B | 1.29B | 1.01B | 27.09 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | The Benchmark Company | Buy |
| 2024-07-03 | Iniziato | Stifel | Buy |
| 2018-02-02 | Iniziato | Chardan Capital Markets | Buy |
Kamada Ltd Borsa (KMDA) Ultime notizie
Lilach Asher Topilsky At Kamada Secures Company Stock Options: $166K Acquired - Benzinga
Strategic Investment: Uri Botzer Boosts Portfolio With $148K In Kamada Stock Options - Benzinga
Kamada (KMDA) director Ishay Davidi's previously reported options carry three adjusted exercise prices. - Stock Titan
A special cash dividend adjusted the exercise prices on Kamada (KMDA) director Uri Botzer’s options. - Stock Titan
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth - TradingView
Form 4 KAMADA LTD For: 27 September By Investing.com - Investing.com Nigeria
Form 4 KAMADA LTD For: 26 September - Investing.com India
Form 4 KAMADA LTD For: 26 September By Investing.com - Investing.com Nigeria
Big News: Lilach Payorski Adds $136K In Kamada Stock Options Io Portfolio - Benzinga
Amir London Makes Strategic Play: Invests $1.80M In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 25 September By Investing.com - Investing.com Canada
A special dividend changed the exercise prices on two stock-option awards for Kamada (KMDA)'s CEO. - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Grants 86,500 Derivative Securities to Director Goldwasser Karnit - Kalkine Media
A dividend changed the exercise prices on options acquired by a Kamada (KMDA) director. - Stock Titan
Kamada (KMDA) HR VP receives two option awards that vest in four annual installments. - Stock Titan
Capitalizing On Growth Prospects, David Tsur Acquires A Substantial $59K In Kamada Stock Options - Benzinga
Capitalizing On Growth Prospects, Hanni Neheman Acquires A Substantial $115K In Kamada Stock Options - Benzinga
Nir Livneh Executes Major Move: Acquires $171K In Kamada Stock Options - Benzinga
Insider Activity Spotlight: Karnit Goldwasser Acquires $154K In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 24 September By Investing.com - Investing.com Canada
Three option awards for a Kamada (KMDA) director carry prices from $5.99 to $7.41 per share. - Stock Titan
A special cash dividend led Kamada (KMDA) to adjust a VP’s stock option prices to $5.98 and $7.44. - Stock Titan
A cash dividend lowered the exercise prices of options awarded to Kamada (KMDA) counsel Nir Livneh. - Stock Titan
Kamada (KMDA) VP’s option prices were adjusted for a special dividend: $5.98 and $7.44 a share. - Stock Titan
Options for Kamada (KMDA) director Leon Recanati vest 25% a year and expire after 10 years. - Stock Titan
A special dividend changed the exercise prices on Kamada (KMDA) CFO's stock options. - Stock Titan
Dividend-linked option reset for Kamada (KMDA) VP - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Director Tsur David Granted 37,500 Derivative Securities on August 27, 2026 - Kalkine Media
Kamada (KMDA) director reports 46,000 options at $6.10–$7.38 - Stock Titan
Kamada (NASDAQ: KMDA) grants director 46,000 options; exercise prices adjusted for dividend - Stock Titan
Stock options for Kamada (NASDAQ: KMDA) VP priced at $5.98 and $7.44 - Stock Titan
David Tsur Executes Major Move: Acquires $61K In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 23 September - Investing.com India
Form 4 KAMADA LTD For: 23 September By Investing.com - Investing.com Canada
Special-dividend-adjusted options for Kamada (KMDA) VP - Stock Titan
Kamada (NASDAQ: KMDA) grants director 37,500 share options - Stock Titan
Kamada Ltd. stock holds gains after recent move in healthcare sector - AD HOC NEWS
Kamada Stock Price Forecast. Should You Buy KMDA? - StockInvest.us
StoneX reiterates Kamada stock buy rating on rabies treatment supply By Investing.com - Investing.com India
StoneX reiterates Kamada stock buy rating on rabies treatment supply - Investing.com
Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem With 55.71% Potential Upside - DirectorsTalk Interviews
Kamada VP of Quality Yael Brenner Executes Five Stock Option Grants on September 14, 2026 - Kalkine Media
Kamada Ltd Director David Tsur Sells 22,827 Shares in September 2026 Transaction - Kalkine Media
Kamada (NASDAQ: KMDA) VP exercises options, uses 7,395 shares to cover costs - Stock Titan
Net option move leaves Kamada (KMDA) legal chief 3,459 shares - stocktitan.net
Kamada Maintains 'Sufficient' KedRAB Supply, Production Capacity Amid Increasing Rabies Exposures in US - marketscreener.com
Kamada Assures Adequate KedRAB Supply as U.S. Rabies Exposures Surge - tipranks.com
Rising U.S. rabies exposures test supply; Kamada (NASDAQ: KMDA) says it is ready - Stock Titan
About 1.4 million people seek rabies care yearly. Kamada says supply is ready. - Stock Titan
CDC Highlights Significant Increase in U.S. Rabies - GlobeNewswire
KAMADA LTD SEC Filing (Sep 16, 2026) - Stock Titan
Kamada Ltd Azioni (KMDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kamada Ltd Azioni (KMDA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Livneh Nir | VP, General Counsel |
Sep 14 '26 |
Option Exercise |
5.37 |
10,000 |
53,700 |
10,000 |
| Tsur David | Director |
Sep 14 '26 |
Sale |
8.18 |
22,827 |
186,725 |
407,929 |
| Tsur David | Director |
Sep 08 '26 |
Sale |
8.26 |
162,760 |
1,344,398 |
430,931 |
| Tsur David | Director |
Sep 07 '26 |
Sale |
8.28 |
14,238 |
117,891 |
593,691 |
| Tsur David | Director |
Sep 09 '26 |
Sale |
8.26 |
175 |
1,446 |
430,756 |
| Tsur David | Director |
Sep 02 '26 |
Option Exercise |
6.71 |
49,000 |
328,690 |
634,429 |
| Brenner Yael | VP Quality |
Sep 02 '26 |
Option Exercise |
5.94 |
3,036 |
18,034 |
9,302 |
| Brenner Yael | VP Quality |
Aug 26 '26 |
Option Exercise |
6.25 |
30,000 |
187,500 |
16,266 |
1.15%
5.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):